Skip to main content

Table 2 Event rates of the composite endpoints

From: Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction

 

mrEF

rEF

β-blocker ( +) (n = 163)

β-blocker ( −) (n = 153)

β-blocker ( +) (n = 99)

β-blocker ( −) (n = 102)

All-cause death, n (%)

30 (18.4)

30 (19.6)

25 (25.3)

52 (51.0)

Non-fatal ACS, n (%)

13 (8.0)

23 (15.0)

6 (6.1)

9 (8.8)

  1. ACS acute coronary syndrome, mrEF mid-range ejection fraction, rEF reduced ejection fraction
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us